<DOC>
	<DOC>NCT01326611</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of clarithromycin in eradication of ureaplasma urealyticum and prevention of chronic lung disease in premature infants with birthweight &lt; 1250 g and have ureaplasma urealyticum colonization.</brief_summary>
	<brief_title>Efficacy of Clarithromycin Treatment in Prevention of Chronic Lung Disease in Premature Infants</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Clarithromycin</mesh_term>
	<criteria>The babies under 1250 gram The babies must be appropriate for gestational age Multiple congenital anomalies or known syndromes Intrauterine growth retardation with birthweight less than 10 percentile for gestational age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Days</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Chronic lung disease</keyword>
	<keyword>Clarithromycin</keyword>
	<keyword>Ureaplasma urealyticum</keyword>
</DOC>